Alterations in glucose metabolism (45), high glucose acting as a preconditioning mimetic in nondiabetic myocytes (47,48) |
Abnormal calcium handling – calcium preconditioning (50) |
Increased production of reactive oxygen species (4,56) coupled with higher levels of antioxidants (42,49) |
Increased activation of protein kinase C epsilon (64,65) |
Increased mitogen-activated protein kinase activity, enhanced activation of extracellular signal-regulated kinases 1 and 2 (51,52) |
Increased phosphoinositide 3-kinase/Akt activity, endothelial nitric oxide synthase activity (48,53,54) |
Increased hypoxia-inducible factor 1-alpha, vascular endothelial growth factor; decreased inflammation and fibrosis (55) |